Genetics and breast cancer risk prediction - Are we there yet?

Journal of the National Cancer Institute

Volumn 102, Issue 21, 2010, Pages 1605-1606

  Cook, Nancy R ^a   Paynter, Nina P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER PATIENT; CANCER RISK; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; DIABETES MELLITUS; DRUG SAFETY; EDITORIAL; GENE MUTATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; ONCOGENE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

BAYES THEOREM; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; MODELS, STATISTICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS;

EID: 78149289047     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq413     Document Type: Editorial

References (15)

1. Robson M, Offi t K. Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med. 2007; 357 (2): 157-162.
2. Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BAJ. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002; 31 (1): 33-36.
3. Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA. Assessment of clincal validity of a breast cancer risk model combining genetic and clinical information. J Nat Canc Inst. 2010; 102 (21): 1618-1627.
4. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007; 115 (7): 928-935.
5. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions using risk stratifi cation tables. Ann Intern Med. 2008; 149 (10): 751-760.
6. Pencina MJ, D ' Agostino RB Sr, D'Agostino RB Jr., Vasan RS. Evaluating the added predictive ability of a new biomarker: from area under the ROC curve to reclassifi cation and beyond. Stat Med. 2008; 27 (2): 157-172.
7. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassifi cation measures. Ann Intern Med. 2009; 150 (11): 795-802.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285 (19): 2486-2497.
9. Viswanathan K, Chlebowski RT, Hurley P, et al. American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. J Clin Oncol. 2009; 27 (19): 3235-3258.
10. Mihaescu R, van Zitterman M, van Houk M, et al. Improvement of risk prediction by genomic profi ling: reclassifi cation measures versus the area under the receiver operating characteristic curve. Am J Epidemiol. 2010; 172 (3): 353-361.
11. Janes H, Pepe MS. Matching in studies of classifi cation accuracy: Implications for analysis, effi ciency, and assessment of incremental value. Biometrics. 2008; 64 (1): 1-9.
12. Cook NR. Comments on 'Evaluating the added predictive ability of a new biomarker: from area under the ROC curve to reclassifi cation and beyond '. Stat Med. 2008; 27 (2): 191-195.
13. Wacholder S, Hartge P, Prentice RL, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med. 2010; 362 (11): 986-983.
14. Talmud PJ, Hingorani AD, Cooper JA, et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study [published online ahead of print January 14, 2010]. BMJ. 2010; 340 : b4838 doi:10.1136/bmj.b4838.
15. Paynter NP, Chasman DI, Pare G, et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA. 2010; 303 (7): 631-637.